Safety and Efficacy of APD811 in Pulmonary Arterial Hypertension
Public ClinicalTrials.gov record NCT02279160. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Parallel-group, Placebo-controlled Phase 2 Trial of Ralinepag, an Oral IP Receptor Agonist, in Patients With Pulmonary Arterial Hypertension
Study identification
- NCT ID
- NCT02279160
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- United Therapeutics
- Industry
- Enrollment
- 61 participants
Conditions and interventions
Conditions
Interventions
- APD811 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2014
- Primary completion
- May 31, 2017
- Completion
- May 31, 2017
- Last update posted
- Jul 13, 2020
2014 – 2017
United States locations
- U.S. sites
- 12
- U.S. states
- 8
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35233 | — |
| Cedars-Sinai Medical Center | Los Angeles | California | 90048 | — |
| UC Davis Medical Center | Sacramento | California | 95817 | — |
| UCLA Medical Center | Torrance | California | 90502 | — |
| University of Iowa Hospitals and Clinics | Iowa City | Iowa | 52242 | — |
| University of Maryland | Baltimore | Maryland | 21201 | — |
| Boston University Medical Center | Boston | Massachusetts | 02118 | — |
| University of Cincinnati | Cincinnati | Ohio | 45267 | — |
| Ohio State University Medical Center | Columbus | Ohio | 43221 | — |
| University of Pittsburg Medical Center | Pittsburgh | Pennsylvania | 15229 | — |
| UT Southwestern | Dallas | Texas | 75390 | — |
| University of Texas, Houston Center for Clinical and Translational Sciences | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 23 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02279160, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 13, 2020 · Synced May 16, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02279160 live on ClinicalTrials.gov.